Answers are grounded in this paper and cite their sources.
Efficient engineering of human and murine primary T cells without perturbation of cellular function is crucial for immunotherapy and immunology research. Here, we present a protocol for genome editing of primary T cells with minimal toxicity using peptide-assisted genome editing. We describe key steps required for primary T cell isolation and activation, CRISPR ribonucleoprotein (RNP) assembly and delivery mediated by peptide, and assessment of editing efficiency. This protocol maintains T cell proliferative capacity and functional potency. For complete details on the use and execution of this protocol, please refer to Zhang et al. 1 1. Zhang, Z. ∙ Baxter, A.E. ∙ Ren, D. ... Efficient engineering of human and mouse primary cells using peptide-assisted genome editing Nat. Biotechnol. 2024; 42 :305-315 Crossref Scopus (91) PubMed Google Scholar
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: